Log in to save to my catalogue

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induce...

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induce...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4585776

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

About this item

Full title

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2015-09, Vol.5 (1), p.14405-14405, Article 14405

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Accumulating evidence suggests that the gut microbiota is an important factor in mediating the development of obesity-related metabolic disorders, including type 2 diabetes. Metformin and berberine, two clinically effective drugs for treating diabetes, have recently been shown to exert their actions through modulating the gut microbiota. In this st...

Alternative Titles

Full title

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4585776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4585776

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep14405

How to access this item